Long entry for GILD predicted by our AI algorithm. The time horizon of the prediction is approximately 5 days.
not sure about the WXY correction wave because the first zigzag is not really one (c truncated don't like it so much but bc=61,8% of ab so also not that bad) anyway triangle in formation right now so possible trace with a low risk ratio we would assume a wave 3 is coming 1) either enter then the triangle is broken with a stop under the e branch of the triangle 2)...
$GLD (Gilead Sciences Inc.). Confluence point between R/S flip, uptrend line and EMAs 2o and 200. Weekly chart.
Identification of a double bottom pattern, downtrend line and EMA 200 trend indicator in GILD
I think GILD is going to want to cool off a bit now after it's nice run. RSI is overbought, Large sell wick on the daily, bearish divergence. We may see a drop over the next several days back down to the bottom of the trend line before it goes back up again.
Short entry for GILD predicted by our AI algorithm. The time horizon of the prediction is approximately 5 days.
GILD has broken out of its ascending triangle on the monthly
Short entry for GILD predicted by our AI algorithm. The time horizon of the prediction is approximately 5 days.
Gets a daily close above 70.69 could be breaking out of a big wedge. Keep eyes on this for a potential big move. Keep stops tight below 68
Looks like the base is formed and a reversal is on track. Target 1&2 - Dotted lines.
Trend(OBV) uses True Strength Index to analyze "On-Balance-Volume", which measures buying and selling pressure as a cumulative indicator. The Trend(OBV) crossed above its signaling Bollinger Band. This is a sign of bullish character. In addition, both Bollinger band and Donchian channel of the Trend(OBV) display squeezes. Can GILD break out and rally from the...
FUNDAMENTALS: GILD ( Gilead Sciences ) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D. ***Revenue is also generated when more...
Main resistance 69.5 (Alarm set for breaking and stabilizing above). I do not recommend buying or sell GILD stocks.